SCM
EXAS

Silvant Capital Management’s Exact Sciences EXAS Stock Holding History

Silvant Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-14,332
Closed -$805K – 307
2024
Q4 		$805K Sell
14,332
-106
-0.7% -$6.6K 0.03% 151
2024
Q3 		$984K Sell
14,438
-408
-3% -$23K 0.04% 144
2024
Q2 		$627K Sell
14,846
-216
-1% -$11.9K 0.03% 149
2024
Q1 		$1.04M Buy
15,062
+943
+7% +$59.6K 0.05% 149
2023
Q4 		$1.04M Sell
14,119
-2,181
-13% -$143K 0.06% 140
2023
Q3 		$1.11M Sell
16,300
-783
-5% -$66.4K 0.07% 143
2023
Q2 		$1.6M Buy
17,083
+1,123
+7% +$87.6K 0.09% 124
2023
Q1 		$1.08M Sell
15,960
-318
-2% -$20.4K 0.07% 130
2022
Q4 		$806K Buy
16,278
+270
+2% +$11K 0.06% 135
2022
Q3 		$520K Sell
16,008
-96
-0.6% -$3.96K 0.04% 148
2022
Q2 		$635K Buy
16,104
+26
+0.2% +$1.39K 0.15% 94
2022
Q1 		$1.12M Sell
16,078
-209
-1% -$15.3K 0.21% 83
2021
Q4 		$1.27M Sell
16,287
-765
-4% -$67.5K 0.22% 84
2021
Q3 		$1.63M Sell
17,052
-3,409
-17% -$360K 0.29% 76
2021
Q2 		$2.54M Sell
20,461
-370
-2% -$44.2K 0.4% 65
2021
Q1 		$2.75M Sell
20,831
-640
-3% -$87.6K 0.47% 58
2020
Q4 		$2.85M Sell
21,471
-429
-2% -$51.9K 0.49% 54
2020
Q3 		$2.23M Sell
21,900
-5,796
-21% -$501K 0.42% 63
2020
Q2 		$2.41M Sell
27,696
-1,851
-6% -$148K 0.43% 60
2020
Q1 		$1.71M Sell
29,547
-591
-2% -$48K 0.37% 73
2019
Q4 		$2.79M Sell
30,138
-365
-1% -$32.1K 0.51% 55
2019
Q3 		$2.76M Sell
30,503
-4,121
-12% -$470K 0.54% 55
2019
Q2 		$4.09M Buy
34,624
+11,241
+48% +$1.13M 0.73% 36
2019
Q1 		$2.03M Buy
+23,383
New +$1.99M 0.36% 76

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Silvant Capital Management's EXAS Position: Q1 2025 in Review

Silvant Capital Management sold out of Exact Sciences (EXAS) in Q1 2025, closing a stake of 14,332 shares — an estimated $805K sold.

Silvant Capital Management first reported a position in EXAS in Q1 2019 and held it in 24 quarters. The position peaked at $4.09M in Q2 2019. 556 funds tracked by Wall St. Rank hold EXAS as of Q1 2025.

  • Silvant Capital Management reported no remaining Exact Sciences position as of Q1 2025 after selling out during the quarter.
  • Silvant Capital Management sold 14,332 Exact Sciences shares in Q1 2025, an estimated $805K.
  • Silvant Capital Management first reported a position in Exact Sciences in Q1 2019 and held it in 24 quarters.
  • Silvant Capital Management's Exact Sciences position peaked at $4.09M in Q2 2019.
  • 556 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2025.

Based on Silvant Capital Management's 13F filing for Q1 2025, filed 14 May 2025.